EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pilot Study on High-Intensity Focused Ultrasound (HIFU) for Basal Cell Carcinoma: Effectiveness and Safety

Jacek Calik, Natalia Sauer iD, Bartosz Woźniak, Andrzej Wojnar, Paweł Pietkiewicz iD, Piotr Dzięgiel

Journal of Clinical Medicine · 01.06.2024 · 13 (11) · 3277

DOI: 10.3390/jcm13113277 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 01.06.2024. Verfasst von Jacek Calik und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Oncology, Wroclaw Medical University, 50-556 Wroclaw, Poland. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The rising incidence of Basal Cell Carcinoma (BCC), especially among individuals with significant sun exposure, underscores the need for effective and minimally invasive treatment alternatives. Traditional surgical approaches, while effective, often result in notable cosmetic and functional limitations, particularly for lesions located on the face. This study explores High-Intensity Focused Ultrasound (HIFU) as a promising, non-invasive treatment option that aims to overcome these challenges, potentially revolutionizing BCC treatment by offering a balance between efficacy and cosmetic outcomes.

Methods

Our investigation enrolled 8 patients, presenting a total of 15 BCC lesions, treated with a 20 MHz HIFU device. The selection of treatment parameters was precise, utilizing probe depths from 0.8 mm to 2.3 mm and energy settings ranging from 0.7 to 1.3 Joules (J) per pulse, determined by the lesion’s infiltration depth as assessed via pre-procedure ultrasonography. A key component of our methodology included dermatoscopic monitoring, which allowed for detailed observation of the lesions’ response to treatment over time. Patient-reported outcomes and satisfaction levels were systematically recorded, providing insights into the comparative advantages of HIFU.

Results

Initial responses after HIFU treatment included whitening and edema, indicative of successful lesion ablation. Early post-treatment observations revealed minimal discomfort and quick recovery, with crust formation resolving within two weeks for most lesions. Over a period of three to six months, patients reported significant improvement, with lesions becoming lighter and blending into the surrounding skin, demonstrating effective and aesthetically pleasing outcomes. Patient satisfaction surveys conducted six months post-treatment revealed high levels of satisfaction, with 75% of participants reporting very high satisfaction due to minimal scarring and the non-invasive nature of the procedure. No recurrences of BCC were noted, attesting to the efficacy of HIFU as a treatment option.

Conclusions

The findings from this study confirm that based on dermoscopy analysis, HIFU is a highly effective and patient-preferred non-invasive treatment modality for Basal Cell Carcinoma. HIFU offers a promising alternative to traditional surgical and non-surgical treatments, reducing the cosmetic and functional repercussions associated with BCC management. Given its efficacy, safety, and favorable patient satisfaction scores, HIFU warrants further investigation and consideration for broader clinical application in the treatment of BCC, potentially setting a new standard in dermatologic oncology care. This work represents a pilot study that is the first to describe the use of HIFU in the treatment of BCC.

Schlagwörter

Stichwörter der Autor:innen

Basal Cell Carcinoma (BCC)High-Intensity Focused Ultrasound (HIFU)dermoscopic analysisnon-surgical skin cancer treatment

Autor:innen und Institutionen

  • Department of Clinical Oncology, Wroclaw Medical University, 50-556 Wroclaw, Poland.
  • Old Town Clinic, 50-136 Wroclaw, Poland.
  • Department of Clinical Pharmacology, Faculty of Pharmacy, Wroclaw Medical University, 50-556 Wroclaw, Poland.
  • Department of Preclinical Sciences, Pharmacology and Medical Diagnostics, Wrocław University of Science and Technology, 50-370 Wrocław, Poland.
  • Zwierzyniecka Medical Center, Zwierzyniecka 30/28, 60-814 Poznań, Poland.
  • Polish Dermatoscopy Group, 61-683 Poznan, Poland.

ORCID-Profile: Natalia Sauer, Paweł Pietkiewicz

Zitieren

APA

Calik, J., Sauer, N., Woźniak, B., Wojnar, A., Pietkiewicz, P., & Dzięgiel, P. (2024). Pilot Study on High-Intensity Focused Ultrasound (HIFU) for Basal Cell Carcinoma: Effectiveness and Safety. Journal of Clinical Medicine, 13(11), 3277. https://doi.org/10.3390/jcm13113277

Vancouver

Calik J, Sauer N, Woźniak B, Wojnar A, Pietkiewicz P, Dzięgiel P. Pilot Study on High-Intensity Focused Ultrasound (HIFU) for Basal Cell Carcinoma: Effectiveness and Safety. Journal of Clinical Medicine. 2024;13(11):3277. doi:10.3390/jcm13113277

BibTeX
@article{Calik2024,
  author = {Calik, Jacek and Sauer, Natalia and Woźniak, Bartosz and Wojnar, Andrzej and Pietkiewicz, Paweł and Dzięgiel, Piotr},
  title = {Pilot Study on High-Intensity Focused Ultrasound (HIFU) for Basal Cell Carcinoma: Effectiveness and Safety},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {13},
  number = {11},
  pages = {3277},
  doi = {10.3390/jcm13113277}
}
Kostenlos starten →